Gland Pharma Ltd. (GLAND) Share Price Hits Fresh 52-Week High at Rs 3,055
- October 7, 2026
- Posted by: Kunal Singla
- Category: News
Gland Pharma Share Price is in focus after the stock touched a fresh 52-week high of Rs 3,055 and last traded at Rs 3,050, up Rs 43.10 or 1.43% from the previous close of Rs 3,006.90. Gland Pharma Ltd. has a market capitalisation of Rs 48,067.66 crore, placing the move in a sizeable healthcare name that is already close to the day’s top. The stock opened at Rs 3,021.05 and moved between Rs 3,021 and Rs 3,055 in early trade.For readers tracking Gland Pharma Share Price Today, the fresh 52-week high is the key event, while Gland Pharma Share Price news flow, valuation and sector comparison help frame the move.
Gland Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,050 |
| Previous Close | Rs 3,006.9 |
| Today's Move | +Rs 43.1 (+1.43%) |
| Open | Rs 3,021.05 |
| High | Rs 3,055 |
| Low | Rs 3,021 |
| Market Capitalisation | Rs 48,067.66 crore |
Gland Pharma Ltd. (GLAND) traded at Rs 3,050 versus the previous close of Rs 3,006.9, a rise of 1.43%. The stock opened at Rs 3,021.05, reached a high of Rs 3,055 and touched a low of Rs 3,021.
Gland Pharma Share Price Today shows a firm start to the trading day, with the stock opening above the previous close and then touching Rs 3,055, which is also the fresh 52-week high. The current trade at Rs 3,050 sits Rs 43.10 above the previous close of Rs 3,006.90, and the day range has been tight so far, between Rs 3,021 and Rs 3,055. That makes the current Gland Pharma Share Price sit just Rs 5 below the day’s peak. The setup is relevant because the stock is already trading close to the fresh yearly high rather than drifting away from it. In Gland Pharma Share Price terms, the market is clearly pricing the stock near its intraday high, and that keeps the event in focus for stock analysis on Univest.
Why Gland Pharma Ltd. (GLAND) May Be Moving Today
Gland Pharma Ltd. (GLAND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 48,067.66 crore |
| P/E Ratio | 43.96x |
| P/B Ratio | 4.67x |
| ROE | 10.56% |
| ROCE | 14.96% |
| EPS | Rs 68.41 |
| Book Value Per Share | Rs 644.16 |
| Dividend Yield | 0.67% |
Gland Pharma Ltd. (GLAND) fundamental metrics show P/E 43.96x, P/B 4.67x, ROE 10.56%, ROCE 14.96%. These figures provide context only and are not a buy or sell signal.
Gland Pharma Ltd. has a market capitalisation of Rs 48,067.66 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 43.96x, P/B at 4.67x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.56% and ROCE of 14.96%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 68.41, book value per share of Rs 644.16, dividend yield of 0.67%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.86x, median ROE of 11.78%, median ROCE of 13.61%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 43.96x |
| Benchmark Median P/E | 31.86x |
| Benchmark Average P/E | 48.48x |
| Benchmark P/E Range | 3.58x to 695.67x |
| Company P/B Ratio | 4.67x |
| Benchmark Median P/B | 2.93x |
| Company ROE | 10.56% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 14.96% |
| Benchmark Median ROCE | 13.61% |
| Company Market Capitalisation | Rs 48,067.66 crore |
| Benchmark Median Market Cap | Rs 789.87 crore |
Gland Pharma Ltd. (GLAND) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Gland Pharma Ltd. (GLAND) has a P/E ratio of 43.96x, which is above the benchmark median of 31.86x, a difference of +37.98%. On its own, the P/E gap is a valuation reference point, not a trading call.
Gland Pharma Ltd. (GLAND) has a ROE of 10.56%, which is below the benchmark median of 11.78%, a difference of -10.36%. Gland Pharma Ltd. (GLAND) has a ROCE of 14.96%, which is above the benchmark median of 13.61%, a difference of +9.92%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Anthem Biosciences Ltd. | ANTHEM | 48,009.77 | 87.04 | 16.02 | 21.98 | 29.62 |
| Ipca Laboratories Ltd. | IPCALAB | 49,506.57 | 37.7 | 5.82 | 15.88 | 19.41 |
| Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | 46,319.84 | 43.74 | 18.54 | 48.76 | 66.79 |
| Ajanta Pharma Ltd. | AJANTPHARM | 43,590.71 | 39.38 | 9.2 | 25.42 | 32.67 |
| Abbott India Ltd. | ABBOTINDIA | 55,907.87 | 34.39 | 10.73 | 34.67 | 46.72 |
Gland Pharma Ltd. (GLAND) has a P/E ratio of 43.96x compared with the displayed peer median of 39.38x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 10.56% compares with a peer median of 25.42% across the companies shown in the table. ROCE stood at 14.96% versus the displayed peer median of 32.67%, providing a capital-efficiency comparison. Gland Pharma Ltd. (GLAND) has a market capitalisation of Rs 48,067.66 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Gland Pharma
- Gland Pharma Share Price touched a fresh 52-week high of Rs 3,055 and last traded at Rs 3,050.
- Gland Pharma Share Price is up Rs 43.10, or 1.43%, from the previous close of Rs 3,006.90.
- Gland Pharma Share Price has a P/E ratio of 43.96 and a P/B ratio of 4.67.
- Gland Pharma Share Price shows ROE of 10.56% and ROCE of 14.96%.
- Gland Pharma Share Price is compared with same-industry peers in healthcare and pharmaceuticals & drugs.
About Gland Pharma
Gland Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Gland Pharma Share Price readers usually track it alongside the company’s valuation, revenue and return metrics because the stock is part of a broader pharmaceutical set. The latest reported quarterly revenue stands at Rs 1,800.27 crore for Jun 2026, while the company’s market capitalisation is Rs 48,067.66 crore. Gland Pharma Share Price is therefore often discussed in the context of earnings quality, book value and capital returns rather than only intraday movement.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Gland Pharma Share Price today?
Ans. Gland Pharma Share Price last traded at Rs 3,050, after touching a fresh 52-week high of Rs 3,055. The stock is up 1.43% from the previous close of Rs 3,006.90 in early trade.
Why did Gland Pharma Share Price touch a fresh 52-week high?
Ans.A news item on the same day discussed a broker rating and target price.
What is the market capitalisation of Gland Pharma?
Ans. Gland Pharma has a market capitalisation of Rs 48,067.66 crore. That places Gland Pharma Share Price in a large company bracket within the healthcare universe, without changing the valuation questions that matter to investors.
How is Gland Pharma Share Price valued versus its sector?
Ans. Gland Pharma Share Price trades at a P/E of 43.96 versus the same-industry median of 31.86 and a P/B of 4.67 versus 2.93. ROCE at 14.96% is above the benchmark median of 13.61%.
What do EPS and book value mean for Gland Pharma Share Price?
Ans. EPS of Rs 68.41 shows earnings attributable to each share, while book value of Rs 644.16 shows accounting net worth per share. Both figures are important when assessing Gland Pharma Share Price alongside valuation multiples.
Is dividend yield relevant for Gland Pharma Share Price?
Ans. Yes. Dividend yield is 0.67%, which shows the historical payout relative to the current share price. For Gland Pharma Share Price, that is a modest income signal compared with the larger focus on valuation and growth metrics.
How does Gland Pharma compare with peer companies?
Ans. Compared with peers, Gland Pharma Share Price sits above Ipca Laboratories and Abbott India on P/E, but below Anthem Biosciences and Glaxosmithkline Pharmaceuticals on return metrics. Peer comparison keeps the valuation debate grounded.
What sector does Gland Pharma operate in?
Ans. Gland Pharma operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. That industry context is central to Gland Pharma Share Price analysis because sector valuation and profitability benchmarks shape comparison.
Track Gland Pharma Share Price on Univest
Use Gland Pharma Ltd. (GLAND) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Gland Pharma Share Price on Univest for live price updates, fundamental ratios, 52-week levels, valuation context and sector comparisons. Gland Pharma Share Price pages also help readers follow the latest market update, peer comparison and company overview in one place.
